Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Erkut Borazancı

A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid Tumors

scientific article published on 21 June 2019

A Phase Ib Study of Single Agent Idelalisib Followed by Idelalisib in Combination with Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma

scientific article published on 30 April 2020

A super-enhancer-regulated RNA-binding protein cascade drives pancreatic cancer

scientific article published on 6 September 2023

Adenosquamous carcinoma of the pancreas: Molecular characterization of 23 patients along with a literature review

scientific article

An Analysis of Patients with DNA Repair Pathway Mutations Treated with a PARP Inhibitor

scientific article published on 07 August 2019

Association of core-binding factor β with the malignant phenotype of prostate and ovarian cancer cells.

scientific article published on November 2010

Effect of Gemcitabine and nab-Paclitaxel With or Without Hydroxychloroquine on Patients With Advanced Pancreatic Cancer: A Phase 2 Randomized Clinical Trial

scientific article published on 01 July 2019

Family communication and patient distress after germline genetic testing in individuals with pancreatic ductal adenocarcinoma

scientific article published on 12 April 2019

Nab-paclitaxel and gemcitabine for the treatment of patients with metastatic pancreatic cancer

scientific article

Neo-adjuvant therapy for pancreatic cancer: hope for the future

scientific article published on 02 May 2019

Pancreatic Cancer: "A Riddle Wrapped in a Mystery inside an Enigma".

scientific article published in April 2017

Potential actionable targets in appendiceal cancer detected by immunohistochemistry, fluorescent in situ hybridization, and mutational analysis

scientific article published on February 2017

Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma

scientific article published on 01 August 2018

RUNX1 (AML-1) and RUNX2 (AML-3) cooperate with prostate-derived Ets factor to activate transcription from the PSA upstream regulatory region.

scientific article

Results from a Phase IIb, Randomized, Multicenter Study of GVAX Pancreas and CRS-207 Compared with Chemotherapy in Adults with Previously Treated Metastatic Pancreatic Adenocarcinoma (ECLIPSE Study)

scientific article published on 24 May 2019

Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring

scientific article published on 17 April 2019

Triptolide and Its Derivatives as Cancer Therapies

scientific article published on 08 April 2019

US phase 1 first-in-human study of taletrectinib (DS-6051b/AB-106), a ROS1/TRK inhibitor, in patients with advanced solid tumors

scientific article published on 26 June 2020

Use of Precision Imaging in the Evaluation of Pancreas Cancer

scientific article published on 01 January 2019